The present findings provide a new insight into evidence that small-molecule Ca acts as a selective leptin-sensitizer in the liver through upregulation of endogenous Leprb expression, which attenuated hepatosteatosis, leading to improvement of insulin resistance and hyperglycemia in obese mice. The gene discussed is LEP; the disease is Hyperglycemia.